Detection in a premature state is vital since with a quick action and simple treatment can prevent the development of visual disability and blindness.


RetinaLyze checks efficiently and quickly possible changes in the retina caused by diabetic retinopathy (DR) and / or the Macular Degeneration with age (DMAE).


RetinaLyze offers concrete and effective results in just 30 seconds. If lesions are detected, the final diagnosis should always be performed by an ophthalmologist.


RetinaLyze team is composed by different people, all very passionate about their area of specialty. Please contact us at any time.
RetinaLyze’s mission is to prevent vision loss. Diabetes is a problem that is advancing around the world and it is estimated that by 2020 there will be over 300 million registered diabetic (type 1 or 2). In addition, by then it is estimated that the number of unregistered diabetics will exceed 250 million. One of the most feared consequences of diabetes is diabetic retinal pathology since it may lead to blindness. It is therefore essential to make an early diagnosis, which is possible through RetinaLyze.

Choose RetinaLyze

96% Percentage of certitude both negative and positive. As reliable as any analysis done with conventional methods but in only 30 seconds.
Facilitates visual inspection to prevent dramatic consequences caused by delayed treatment of retinal lesions.

Percentage of certitude of 96%

Easy handling without an ophthalmologist

In just 30 seconds

Optimizing consultation times

Benefits for patients and professionals

Complies with the European Community Class IIa according to the Medical Device Directive 93/42 / EEC.
Increased patient traffic, optimizing the consultation time, with easy handling without an ophthalmologist
More information »
Allows the detection of retinopathy and maculopathy in early stage for treatment, no waiting, no discomfort and at a low cost.
More information »